UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature

Blood, 2016-12, Vol.128 (24), p.2824-2833

2016

Volltextzugriff (PDF)

Inhibition of complement in Guillain‐Barré syndrome: the ICA‐GBS study

Journal of the peripheral nervous system, 2017-03, Vol.22 (1), p.4-12

2017

Volltextzugriff (PDF)

Detecting fatigue in multiple sclerosis through automatic speech analysis

Frontiers in human neuroscience, 2024-09, Vol.18, p.1449388

2024

Volltextzugriff (PDF)

Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders

Cochrane database of systematic reviews, 2007-01, Vol.2010 (1), p.CD004761

2007

Volltextzugriff (PDF)

An open label clinical trial of complement inhibition in multifocal motor neuropathy

Journal of the peripheral nervous system, 2011-06, Vol.16 (2), p.84-91

2011

Volltextzugriff (PDF)

Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)

Frontiers in neurology, 2024-08, Vol.15, p.1437913

2024

Volltextzugriff (PDF)

Variant CJD in an individual heterozygous for PRNP codon 129

The Lancet (British edition), 2009-12, Vol.374 (9707), p.2128-2128

2009

Volltextzugriff (PDF)

Peripheral neuropathy: pattern recognition for the pragmatist

Postgraduate Medical Journal, 2012-02, Vol.88 (1036), p.88-96

Overell, James R

2012

Volltextzugriff (PDF)

Peripheral neuropathy: pattern recognition for the pragmatist

Practical Neurology, 2011-04, Vol.11 (2), p.62-70

Overell, James R

2011

Volltextzugriff (PDF)

Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case–control studies

Journal of neurology, neurosurgery and psychiatry, 2019-09, Vol.90 (9), p.1059-1067

2019

Volltextzugriff (PDF)

Opioid prescribing patterns following common general surgery procedures in the Bay of Plenty, New Zealand

ANZ journal of surgery, 2023-03, Vol.93 (3), p.597-601

2023

Volltextzugriff (PDF)

Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial

Lancet neurology, 2020-12, Vol.19 (12), p.998-1009

2020

Volltextzugriff (PDF)

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Lancet neurology, 2020-03, Vol.19 (3), p.214-225

2020

Volltextzugriff (PDF)

Thrombotic Microangiopathy Associated with Interferon Beta

The New England journal of medicine, 2014-03, Vol.370 (13), p.1270-1271

2014

Volltextzugriff (PDF)

Diagnosis and management of multiple sclerosis: MRI in clinical practice

Journal of neurology, 2020-10, Vol.267 (10), p.2917-2925

2020

Volltextzugriff (PDF)

Evaluation of NEDA as a Predictor of Disease Progression in Patients With RMS and PPMS Treated With Ocrelizumab: Post-Hoc Analyses From the OPERA I/OPERA II and ORATORIO Trials (P16-4.007)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Effect of Perindopril on Cerebral and Renal Perfusion on Normotensives in Mild Early Ischaemic Stroke: A Randomized Controlled Trial

Cerebrovascular diseases (Basel, Switzerland), 2005-01, Vol.19 (2), p.77-83

2005

Volltextzugriff (PDF)

Reliability and External Validity of Digital Passive Gait Tracking in MS (P6-6.008)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

020 Long-term efficacy of ocrelizumab in relapsing multiple sclerosis: 6 study years

Journal of neurology, neurosurgery and psychiatry, 2022-06, Vol.93 (6), p.A19-A20

2022

Volltextzugriff (PDF)

Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies

Neurology, 2000-10, Vol.55 (8), p.1172-1179

2000

Volltextzugriff (PDF)

Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials

European journal of neurology, 2022-04, Vol.29 (4), p.1238-1242

2022

Volltextzugriff (PDF)

The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke

Journal of hypertension, 2004-05, Vol.22 (5), p.989-995

2004

Volltextzugriff (PDF)

Towards a More User-Friendly Medication Information Delivery to People Living with Multiple Sclerosis: A Case Study with Alemtuzumab

Advances in experimental medicine and biology, 2019, Vol.1120, p.67-82

2019

Volltextzugriff (PDF)

International consensus on quality standards for brain health-focused care in multiple sclerosis

Multiple sclerosis, 2019-11, Vol.25 (13), p.1809-1818

2019

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature

Inhibition of complement in Guillain‐Barré syndrome: the ICA‐GBS study

Detecting fatigue in multiple sclerosis through automatic speech analysis

Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders

An open label clinical trial of complement inhibition in multifocal motor neuropathy

Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)

Variant CJD in an individual heterozygous for PRNP codon 129

Peripheral neuropathy: pattern recognition for the pragmatist

Peripheral neuropathy: pattern recognition for the pragmatist

Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case–control studies

Opioid prescribing patterns following common general surgery procedures in the Bay of Plenty, New Zealand

Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial

Thrombotic Microangiopathy Associated with Interferon Beta

Diagnosis and management of multiple sclerosis: MRI in clinical practice

Evaluation of NEDA as a Predictor of Disease Progression in Patients With RMS and PPMS Treated With Ocrelizumab: Post-Hoc Analyses From the OPERA I/OPERA II and ORATORIO Trials (P16-4.007)

Effect of Perindopril on Cerebral and Renal Perfusion on Normotensives in Mild Early Ischaemic Stroke: A Randomized Controlled Trial

Reliability and External Validity of Digital Passive Gait Tracking in MS (P6-6.008)

Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study

020 Long-term efficacy of ocrelizumab in relapsing multiple sclerosis: 6 study years

Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies

Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials

The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke

Towards a More User-Friendly Medication Information Delivery to People Living with Multiple Sclerosis: A Case Study with Alemtuzumab

International consensus on quality standards for brain health-focused care in multiple sclerosis

Suchergebnisse filtern